市場調查報告書
商品編碼
1410763
關節內粘稠補充療法的全球市場 - 市場規模(各市場區隔),佔有率,法規,償付,治療,預測(~2033年)Viscosupplementation Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
本報告提供全球關節內粘稠補充療法市場相關調查分析,提供各市場區隔的市場規模,市場趨勢,競爭情形,COVID-19影響等資訊。
市場模式的主要內容如下列。
已上市的關節內粘稠補充療法設備與不斷變化的競爭格局
世界,地區,國家層級的市場固有考察
透過掌握包含醫療制度概要的真實整體狀況來促進對市場的認識。此外在打入市場部門更提供關於給付原則及法規情勢之資訊,使您能夠更深入地研究市場動態。
對象企業
Viscosupplementation Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on the Viscosupplementation market for the year 2020 and beyond.
Viscosupplementation is a minimally invasive procedure where hyaluronic acid (an active compound in synovial fluid) is injected into the joints. The procedure is majorly carried out in the knee, followed by the hip, shoulder, ankle, and other joints.
Viscosupplementation treatment regimens have been divided into 1-injection, 3-injection, and 5-injection regimens with 3 and 5-injection treatments showing major effects in pain relief. However, for the past few there has been an ongoing controversy over its effectiveness and sustainability for OA patients. This has decreased the reimbursements given by the government and private insurance companies for treatment over the period of time.
Each of the covered 39 country's color-coded and fully-sourced market models is equipped with epidemiology-based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers the installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Viscosupplementation Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Sanofi , Seikagaku Corp, Bioventus Inc, Anika Therapeutics Inc, Fidia farmaceutici SpA, Ferring Pharmaceuticals AS, Zimmer Biomet Holdings Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable